U.S., Oct. 23 -- ClinicalTrials.gov registry received information related to the study (NCT07219927) titled 'Real-World Patient Experiences Using Continuous Subcutaneous Apomorphine Infusion (ONAPGOTM) in the United States:' on June 09.
Brief Summary: Real-World Participants Experiences Using Continuous Subcutaneous Apomorphine Infusion (ONAPGOTM) in the United States: A Prospective, Phase 4, Multicenter, Observational Study in Parkinson's Disease
Study Start Date: March 31
Study Type: OBSERVATIONAL
Condition:
Parkinson Disease
Intervention:
OTHER: Observational study
Continuous Subcutaneous Apomorphine Infusion (ONAPGOTM)
Recruitment Status: RECRUITING
Sponsor: Supernus Pharmaceuticals, Inc.
Published by HT Digital Content Servi...